The test analyzes key variants including GLP1R rs6923761, which affects how sensitive your appetite control receptors are to GLP-1 signaling, and FTO rs9939609, linked to baseline weight regulation and hunger drive
Before adding any supplements to your routine, consult your healthcare provider
[1] [2] The decision to stop tirzepatide may arise from various circumstances: achievement of treatment goals, intolerable side effects, insurance coverage changes, cost considerations, pregnancy, or medical contraindications (including medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or serious hypersensitivity reactions, as noted in the boxed warning)
Without the support of GLP-1s, patients may need to lean even more on lifestyle strategies like structured exercise, nutrition planning, and ongoing behavioral support to maintain results